Bmab+oral 5-FU therapy is appropriate for first-line treatment of elderly patients with ARCC
Year: 2016
Type: article
Study design: Observational Study
Source: Annals of Oncology
Institutions: Nagasaki University, Nagasaki University Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2586950367
